Changes in plasma lipoxin A4, resolvins and CD59 levels after ischemic and traumatic brain injuries in rats
10.4196/kjpp.2020.24.2.165
- Author:
Jun Sub JUNG
1
;
A Ra KHO
;
Song Hee LEE
;
Bo Young CHOI
;
Shin Hae KANG
;
Jae Young KOH
;
Sang Won SUH
;
Dong Keun SONG
Author Information
1. Institute of Natural Medicine, College of Medicine, Hallym University, Chuncheon 24252, Korea.
- Publication Type:Original Article
- From:The Korean Journal of Physiology and Pharmacology
2020;24(2):165-171
- CountryRepublic of Korea
- Language:English
-
Abstract:
Ischemic and traumatic brain injuries are the major acute central nervous system disorders that need to be adequately diagnosed and treated. To find biomarkers for these acute brain injuries, plasma levels of some specialized pro-resolving mediators (SPMs, i.e., lipoxin A4 [LXA4], resolvin [Rv] E1, RvE2, RvD1 and RvD2), CD59 and interleukin (IL)-6 were measured at 0, 6, 24, 72, and 168 h after global cerebral ischemic (GCI) and traumatic brain injuries (TBI) in rats. Plasma LXA4 levels tended to increase at 24 and 72 h after GCI. Plasma RvE1, RvE2, RvD1, and RvD2 levels showed a biphasic response to GCI; a significant decrease at 6 h with a return to the levels of the sham group at 24 h, and again a decrease at 72 h. Plasma CD59 levels increased at 6 and 24 h post-GCI, and returned to basal levels at 72 h post-GCI. For TBI, plasma LXA4 levels tended to decrease, while RvE1, RvE2, RvD1, and RvD2 showed barely significant changes. Plasma IL-6 levels were significantly increased after GCI and TBI, but with different time courses. These results show that plasma LXA4, RvE1, RvE2, RvD1, RvD2, and CD59 levels display differential responses to GCI and TBI, and need to be evaluated for their usefulness as biomarkers.
